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1. Introduction 
Acetylation and deacetylation of the ~-amino 
groups of specific histone lysyl residues occurs in the 
course of the cell cycle. The overall level of acetyla- 
tion at any given time involves an equilibrium between 
acetate uptake catalysed by nuclear acetyltransferases 
[ 1,2] and acetate removal catalysed by nuclear 
deacetylases [3-51. All the histones that make up the 
chromatin core particle, i.e., histones H2A, H2B, H3 
and H4 are subject, in vivo, to acetylation and 
deacetylation but no acetylation sites have been 
observed on the very lysine-rich histone Hl [2]. 
On the basis of sequence analogies, a classification 
of the acetylation sites into two types (A,B) was 
proposed [2]. In type A there is a single lysyl residue 
surrounded by two non-basic residues and in type B a 
basic doublet such as Lys-Lys, Lys-Arg and Arg- 
Lys. This classification suggests that only a small 
fragment of the histone molecule is necessary for 
enzymatic recognition. However, chemical studies on 
the activity of a calf thymus deacetylase using histone 
H4 fragments, including the monoacetylated peptide 
(15-2 1) H-Ala-Lys”j (Ac)-Arg-His-Arg-Lys- 
Val-OH, led to the conclusion that a rather long 
sequence of the histone molecule is required for 
enzyme recognition [6]. 
Here we report the enzymatic deacetylation of the 
diacetylated histone H4 fragment (14-21) Ac-Gly- 
Ala-Lys-(AC)-Arg-His-Arg-Lys(Ac)-Val-NH?, 
with the N- and C-terminal groups protected by an 
acetyl and an amide group, respectively, in conditions 
similar to those used for the deacetylation of the 
whole histone H4 molecule. 
2. Materials and methods 
2.1. Preparation of substrates 
2.1.1. (i) [ 1 -14C]Acetate-labelled histone H4 
Histone H4, isolated by the method in [7], was 
incubated in the presence of [ l-14k]acetyl-CoA and 
nuclear acetyltransferase from rat liver as in [8]. The 
labelled histone H4 was purified by carboxymethyl 
cellulose (CMC) chromatography and lyophilized. 
2.1.2. Diacetylated peptide [14-211: Ac-Gly-Ala- 
Lys( [2-3H3]acetyl)-Arg-His-Arg-Lys- 
( [2-3H3]acetyl)-Val-NHz 
The peptide (14-2 1) was synthesized as in [8] 
and the e-NH2 groups acetylated using tritiated acetic 
anhydride (spec. act. 50 mCi/mol) by the method in 
[9]. Purification of the diacetylated peptide was 
carried out by gel filtration on Sephadex G-10 and 
analysis by CMC chromatography showed the peptide 
to be fully acetylated. 
2.2. Histone deacetylase extraction 
Calf thymus nuclei were prepared by the method 
in [lo]. The histone deacetylase was extracted as in 
[ 111 and partially purified by DEAE-cellulose 
chromatography using a 0.01-0.4 M N&Cl gradient 
in buffer A (15 mM Tris-HCl (pH 7), 10 mM NH,Cl, 
0.2 mM EDTA, 5 mM 2-mercaptoethanol, 20% 
glycerol, v/v). Fractions showing deacetylase activity 
with labelled histone H4 as a substrate were pooled, 
concentrated by ultrafiltration (Amicon membrane 
UMlO), dialysed against 25 mM Tfis-HCl (pH 7), 
50% glycerol, v/v and stored at -20°C. The protein 
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content was measured by the Lowry method [ 121. SDS- 
polyacryl~ide gel electrophoresis showed the frac- 
tion to be histone free. 
2.3. Assay of deacetylaseactivity with labelled histone 
H4 as substrate 
The method in [3] was used to follow the 
enzymatic deacetylation of histone H4. Labelled his- 
tone H4 (0.8 mg, spec. act. 3870 dpmfmg) was 
incubated at 37°C for 60 min in 0.5 ml 25 mM Tris- 
HCl (pH 7) in the presence of varying amounts of 
enzyme (50- 1200 /.fg total protein). The reaction 
was stopped by adding 0.1 ml 1 M HCl containing 
0.16 M non-radioactive acetic acid as a carrier. Acetic 
acid was extracted from the aqueous phase in 3 ml 
ethylacetate. The radioactivity in 1 ml organic layer, 
corresponding to the [ 1-14C]acetate, was measured 
after adding 10 ml Bray solution [ 131 using an Inter- 
technique (France) liquid scintillation spectrometer. 
3. Results 
Diacetylated peptide (14-2 1) 5 mg, with spec. 
act. SO mCi/mol, was divided into fractions of 0.2 mg. 
Each fraction was incubated in the same conditions 
used for the deacetylation of H4 (see section 2). 
Analysis of the bulked reaction products was carried 
out by CMC chromatography using a linear NaCl 
gradient (fig.1). TheAare peaks, named P, , P, and Pe , 
which were eluted at 0.14 M, 0.22 M and 0.29 M 
NaCl correspond to the di-, mono- and non-acetylated 
peptides (14-21) respectively. 3H-radioactivity is 
found in fractions eluted below 0.1 M NaCl as well as 
in the mono- and diacetylated species. This corresponds 
to free acetate which is not retained in the column 
and to protein-peptide complexes which are eluted 
at 0.07-0.1 M NaCl. 
lit can be seen from fig.1 that the diacetylated 
peptide (14-21) acts as a substrate for a nuclear 
deacetylase and that both acetyl groups on the side- 
chains of Lys16 and Lys2’ are accessible to the 
enzyme. Previous results on the enzymatic acetyla- 
tion of peptide (14-2 1) also showed that both lysyl 
residues are accessible to a nuclear acetylase [S]. 
As radioactive peptide-protein complexes are 
formed in the conditions described in fig. 1, a quan- 
titative analysis using this experimental pproach is 
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Fig.1. Carboxymethyl cellulose (MC) chromatography. After enzymatic deacetylation, the labelled diacetylated peptide 
(4.39 rmol) was applied to a CMC column (1.8 X 9 cm) and eluted with a Linear NaCl gradient (O-O.4 M) with a flow rate of 
43.6 ml/h. Fractions (7 ml) were collected and the radioactivity of 0.4 ml aliquots was measured in 10 ml Bray solution. 
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not possible. In order to establish the relative 
percentage of deacetylation of each residue (Lys” or 
Lys2’), a parallel experiment was carried out using a 
non-radioactive peptide sample. The reaction mixture 
after enzymatic deacetylation was analyzed by CMC 
chromatography using a linear HCl gradient 
(O-O.1 M). It has been established that in these condi- 
tions all peptides, whatever their degree of acetyla- 
tion, are eluted in a single peak [8]. Because of the 
highly basic character of .the peptides Pr and Pe, no 
protein-peptide complexes are likely to occur in 
acidic conditions, The peptide mixture was then 
treated with [3H]acetic anhydride [S] and the pure 
diacetylated peptide (14-2 1) was obtained in 
quantitative yield. This corresponds to a selective 
radioactive labelling of the enzymatic products Pe 
and P, . The radioactive peptide thus obtained allowed 
the specific activity of the enzyme to be estimated at 
-70 pmd acetate released .h-’ .mg protein”. The 
diacetylated peptide (14-21) was then digested with 
trypsin and the fragments resulting from the selective 
cleavage of the polypeptide chain at arginine residues 
were separated by CMC chromatography as in [8]. 
The amount of radioactivity present in the different 
tryptic peptides indicates that the degree of deacetyla- 
tion of Lysi6 (AC) and Lys2’(Ac) is nearly the same 
(54% and 46%, respectively). 
4. Discussion 
The present results how that the acetylated Lys16 
in the octapeptide Ac-Gly-Ala-Lysr6(Ac)-Arg- 
His-Arg-Lys2’ (AC)-Vat-NH, can be deacetylated 
by a calf thymus histone deacetylase inconditions 
similar to those used to deacetylate the histone H4. 
The octapeptide represents he histone H4 fragment 
between residues 14 and 2 1 with the N- and C- 
extremities protected by an acetyl group and a 
primary amide group, respectively. The mono- 
acetylated peptide (15-21) H-Ala-Lys16 (Ac)-Arg- 
His-Arg-Lys-Val-OH with unprotected N- and C- 
extremities was found [6] not to be deacetylated by 
the calf thymus histone deacetylase and they con- 
cluded that recognition by the enzyme requires an 
histone fragment much larger than an heptapeptide. 
However, the results obtained with the protected 
peptide (14-2 1) suggest that the failure to deacetylate 
Lys16 of the unprotected peptide (15-2 1) is due to 
the presence of charged groups at N- and C- 
extremities which are very close to the deacetylation 
site. This is not encountered when the enzyme 
interacts with the intact histone molecule. The 
protected octapeptide (14-2 1) offers a better analogy 
with the situation that occurs in vivo since both the 
N- and C- extremities are uncharged. As the peptide 
(14-2 1) and t&e peptide (15-2 1) differ in length and 
substitution of their sidechains, the possibility that 
the presence of an N-term~l glycine residue and/or 
an NE-acetyl group on Lyszo might affect the 
deacetylation of Lysi6 cannot be excluded. However, 
the fact that deacetylation of Lysr’ readily occurs 
with the protected peptide (14-21) suggests hat the 
histone deacetylase does not require a long fragment 
of the histone H4 in order to recognize the deacetyla- 
tion site in the whole histone molecule. 
The observation that Lys’* is also deacetylated 
in the diacetylated peptide (14-21) suggests hat the 
sequence specificity of the histone deacetylase is not 
very strict. Both the lysyl residues belong to type B 
acetylation sites and only differ by their sequences: 
Lys16 -Arg and Arg-Lys2’, respectively. In 
chromatin the Lyszo of histone H4 is never acetylated 
and is substituted by methyl groups which are likely 
to prevent any acetylation at this site [14]. However, 
Arg-Lys occurs as an acetylation site in the histone 
H3 [2]. We reported [8] that the Lys” and Lyszo in 
the unacetylated peptide (14-21) can both be 
acetylated enzymatically to a similar extent. This 
suggested that the sequence Arg-Lys2’, if unmeth- 
ylated, would be a potential acetylation site in the 
histone H4. ~el~~ary results also show that Lysg’ 
of the histone H4, which is adjacent to an arginyl 
residue (Lys-Arg), can be acetylated when the 
C-terminal fragment of the histone H4 (residues 
85-102) is used as a substrate of the histone acetyl- 
transferase (unpublished). However, no acetylation 
has been detected on Lys’r in vivo [ 151. 
It appears that both the acetylating and deacety- 
lating enzymes which act on B sites have similar 
recognition requirements when interacting with 
histone substrates and that only a restricted sequence 
of the histone molecule is needed for the enzyme- 
substrate complex to be formed. The fact that a 
restricted number of lysyl residues are acetylated in 
chromatin histones is probably related to structural 
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features of the nucleoprotein complex which affect 
the accessibility of the enzymes. The different levels 
of chromatin structure (tertiary structure of the 
chromatin core particle [ 161 and the superstructure 
of the nucleofilament [ 171) are likely to be important 
factors in maintaining the specificity of the enzymatic 
acetylation-deacetylation processes invivo. I-&stone 
deacetylases and acetylases should therefore be useful 
probes to detect different conformational states of 
chromatin. 
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